Immunogenicity of anthracyclines: moving towards more personalized medicine
- 1 April 2008
- journal article
- review article
- Published by Elsevier BV in Trends in Molecular Medicine
- Vol. 14 (4), 141-151
- https://doi.org/10.1016/j.molmed.2008.02.002
Abstract
No abstract availableKeywords
This publication has 102 references indexed in Scilit:
- Immunological aspects of cancer chemotherapyNature Reviews Immunology, 2008
- Molecular characteristics of immunogenic cancer cell deathCell Death & Differentiation, 2007
- Tumor stress, cell death and the ensuing immune responseCell Death & Differentiation, 2007
- The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapyImmunological Reviews, 2007
- Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapyNature Medicine, 2007
- Toll-like receptors in systemic autoimmune diseaseNature Reviews Immunology, 2006
- Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patientsCancer Immunology, Immunotherapy, 2006
- Regulatory T cells, tumour immunity and immunotherapyNature Reviews Immunology, 2006
- Toll-like receptors and innate immunityNature Reviews Immunology, 2001
- Treatment of Breast CancerNew England Journal of Medicine, 1998